GLP 1 News and Research

RSS

Hacking 'drug trafficking' system could increase effectiveness of diabetes treatment

Making tiny changes to existing diabetes treatments can alter how they interact with cells, and potentially make the medicines more effective.

23 Apr 2018

Study compares survival outcomes of different drugs for type 2 diabetes

In a comparison of different classes of drugs used to lower blood sugar levels for patients with type 2 diabetes, sodium-glucose cotransporter 2 (SGLT-2) inhibitors or glucagon-like peptide 1(GLP-1) agonists were associated with a lower risk of death than dipeptidyl peptidase 4 (DPP-4) inhibitors or control (placebo or no treatment).

17 Apr 2018

One class of diabetes drug not associated with reduced risk of death

One class of drug used to treat type 2 diabetes may not reduce the risk of death when compared with placebo, suggests new findings.

17 Apr 2018

New diabetes drug may help obese people shed body weight

A compound that mimics a naturally occurring hormone that regulates appetite may help people who have obesity but not diabetes to lose weight, a new study suggests.

19 Mar 2018

Gastric bypass can provide better outcomes for patients with obesity and diabetes than lifestyle intervention

People with worrisome levels of obesity and poor control of their type 2 diabetes face two dramatically different options to substantially improve their health: bariatric (weight loss) surgery or intensive lifestyle management.

2 Mar 2018

Chemist finds how to control blood sugar without usual side effects

Chemist Robert Doyle in the College of Arts and Sciences at Syracuse University has figured out how to control glucose levels in the bloodstream without the usual side effects of nausea, vomiting or malaise.

11 Feb 2018

Tecan to introduce Fluent Gx Automation Workstation for clinical and regulated laboratories

Tecan’s range of advanced liquid handling solutions will soon be enhanced with the introduction of the new Fluent Gx Automation Workstation, designed specifically to meet the stringent needs of clinical and regulated laboratories.

5 Feb 2018

Diabetes drug holds promise of being developed into new treatment for Alzheimer's

A drug developed for diabetes could be used to treat Alzheimer's after scientists found it "significantly reversed memory loss" in mice through a triple method of action.

2 Jan 2018

Scientists take step toward solving puzzle about heart health in type 2 diabetes

Scientists at Joslin Diabetes Center have taken another step toward solving a long-standing puzzle about heart health in type 2 diabetes, with a finding that eventually may point towards more personalized patient care.

29 Nov 2017

UB researcher explores link between signals in the brain's reward system and overeating, drug addiction

Why are some people able to stop after eating just a few potato chips, while others aren't satisfied until the bag is nothing but crumbs? The answer may lie in the signals acting in the brain's reward system.

9 Nov 2017

METTLER TOLEDO’s new white paper discusses routine tests necessary for moisture analysis

METTLER TOLEDO is pleased to present a new white paper entitled “Moisture Analyzer Routine Testing.” This informative 6-part paper discusses the routine tests necessary to ensure reliable moisture content determination using a halogen moisture analyzer.

From Mettler-Toledo International Inc. 12 Oct 2017

Increased enzyme production by the liver causes fatty liver, obesity and insulin resistance

In mice that are given a high-fat diet, an increased production of the enzyme DPP4 by the liver promotes an increase in body fat, the development of fatty liver disease and insulin resistance.

24 Aug 2017

Common obesity and diabetes drug could be used as novel way to lower brain pressure

Research led by the University of Birmingham, published today in Science Translational Medicine, has discovered that a drug commonly used to treat patients with either obesity or Type II diabetes could be used as a novel new way to lower brain pressure.

23 Aug 2017

GLP 1 News and Research

Hacking 'drug trafficking' system could increase effectiveness of diabetes treatment

Study compares survival outcomes of different drugs for type 2 diabetes

One class of diabetes drug not associated with reduced risk of death

New diabetes drug may help obese people shed body weight

Gastric bypass can provide better outcomes for patients with obesity and diabetes than lifestyle intervention

Chemist finds how to control blood sugar without usual side effects

Tecan to introduce Fluent Gx Automation Workstation for clinical and regulated laboratories

Diabetes drug holds promise of being developed into new treatment for Alzheimer's

Scientists take step toward solving puzzle about heart health in type 2 diabetes

UB researcher explores link between signals in the brain's reward system and overeating, drug addiction

METTLER TOLEDO’s new white paper discusses routine tests necessary for moisture analysis

Increased enzyme production by the liver causes fatty liver, obesity and insulin resistance

Common obesity and diabetes drug could be used as novel way to lower brain pressure

Diabetes drug shows promise as Parkinson’s treatment

Researchers discover differences between mice and humans in function of insulin-producing beta cells

Researchers capture first cryo-EM snapshots of key cellular receptor in action

Researchers discover dual-functional compound that shows potential to combat type 1, type 2 diabetes

DeNovix pink spectrophotometer - fluorometer won by Ukraine National Acaedemy of Science

Special edition pink spectrophotometer-fluorometer to be given away at AACR

Webinar on calibration and routine testing for laboratory equipment

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News